查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1971337

醫藥級碳酸鋰市場－全球產業規模、佔有率、趨勢、機會、預測：依純度、應用、地區和競爭格局分類，2021-2031年

Pharmaceutical Grade Lithium Carbonate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Purity (99%, Above 99%), By Application (Extended Release, Immediate Release), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫藥級碳酸鋰市場預計將從 2025 年的 1.4591 億美元成長到 2031 年的 1.8473 億美元，複合年成長率為 4.01%。

這種高純度無機化合物是一種重要的情緒穩定劑，主要用於治療躁鬱症和躁症發作。其市場基礎在於全球精神疾病發病率的上升和精神衛生保健基礎設施的擴張，這確保了對長期藥物治療的穩定需求。這些基本促進因素賦予了市場穩定性，使其不受工業應用週期的影響，從而保護該行業免受其他化學工業中常見的市場波動。

市場概覽
預測期 2027-2031
市場規模：2025年 1.4591億美元
市場規模：2031年 1.8473億美元
複合年成長率：2026-2031年 4.01%
成長最快的細分市場 緩釋
最大的市場 北美洲

然而，來自電動車市場的激烈競爭給該行業帶來了原料供應的巨大挑戰。對鋰資源的競爭加劇了供應鏈的緊張，並使醫療提煉所需原料的採購變得更加複雜。根據美國地質調查局（USGS）預測，到2024年，電池產業將佔全球鋰消耗量的87%，而醫療產業僅佔約1%。這種巨大的不平衡凸顯了製藥生產極易受到工業供不應求。

市場促進因素

全球雙極性情感障礙和情緒障礙發病率的不斷上升是推動藥用級碳酸鋰市場發展的主要動力。高效情緒穩定劑的持續生產得益於精神疾病診斷準確性的提高、消除歧視的努力取得進展以及需要長期服藥人群的顯著成長。這形成了一個穩定的需求基礎，與電池使用週期性的波動模式形成鮮明對比。主要醫療保健市場受影響人群的龐大規模清晰地印證了這一趨勢。根據2024年10月發布的《2025年美國精神健康狀況報告》，2024年美國成年人中將有23.40%患有精神疾病，這意味著一個龐大的群體可能需要精神科干預。

同時，儘管電池產業佔據主導地位，但高純度鋰精煉和萃取技術的進步對於滿足醫療需求至關重要。加工能力的提升使製造商能夠有效地將藥用級成分與工業級鹽水分離，從而避免供應短缺阻礙基本藥物的生產。這項業務擴張體現在公司近期的各項指標。根據Arcadium Lithium於2025年2月發布的“2024年第四季度及全年財務業績”，第四季度總銷售量（以碳酸鋰當量計）較第三季度成長56%，表明產能有所提升。在市場波動的情況下，產能的擴張對於穩定醫療供應鏈至關重要。根據上海金屬市場數據顯示，2024年底電池用碳酸鋰的平均現貨價格為每噸75,050元人民幣，這意味著在當前的價格環境下，高效的高純度精煉技術在確保醫藥原料供應方面具有顯著的競爭優勢。

市場挑戰

電動車 (EV) 產業對原料的激烈競爭，嚴重阻礙了全球醫藥級碳酸鋰市場的擴張。隨著汽車產業為實現脫碳目標而迅速擴大生產規模，其消耗了大部分可用的鋰原料，為其他高純度應用領域造成了嚴重的瓶頸。這種資源壟斷擾亂了依賴嚴格監管的高等級碳酸鋰的製藥企業的供應鏈。大量原料被轉移到電池製造領域，導致用於醫用級純化的前驅化合物供應不足，使製藥企業面臨供應不穩定和議價能力下降的困境。

資源配置的這種不平衡使得醫療保健產業極易受到大型工業企業籌資策略的影響。由於藥品需求相對小規模，製造商往往難以從礦業公司獲得優先採購名額，而礦業公司則傾向於優先簽訂電池產業特有的大型長期承購合約。近期行業統計數據凸顯了這種不平衡的嚴重程度。根據國際鋰協會預測，2024年全球鋰需求量將達到約130萬噸碳酸鋰當量。這項龐大的消費需求主要由儲能需求驅動，實際上已將醫藥市場邊緣化，使得穩定採購關鍵原料變得越來越困難且高成本。

市場趨勢

神經退化性疾病臨床研究的拓展標誌著市場格局的重大變革，鋰的效用也從傳統的雙極性情感疾患治療擴展到其他領域。日益成長的失智症帶來的經濟和社會影響亟待緩解，這推動了對鋰在阿茲海默症及其他疾病治療中神經保護作用的研究不斷深入。這項轉變將大幅擴大藥用級鋰化合物的潛在患者群，並建立一條獨立於精神科護理的全新長期需求管道。這些疾病帶來的經濟負擔凸顯了這個機會的重要性。根據阿茲海默症協會於2024年3月發布的《2024年阿茲海默症事實與數據》報告，預計到2024年，美國阿茲海默症及其他失智症患者的總照護費用將達到3,600億美元，凸顯了開發有效鋰基治療方法的巨大市場獎勵。

同時，旨在緩解電池行業競爭的區域性供應鏈正在興起，這正在改變籌資策略，以保護醫療庫存免受行業短缺的影響。各國政府正在製定法律，設定國內加工目標，以確保包括製藥在內的關鍵產業能夠獲得必要的礦產資源。這可以防止礦產資源完全被亞洲電池製造網路消耗。這一趨勢迫使醫用鋰精煉商與不受全球出口不穩定影響的區域精煉廠合作。近年來，這項結構性變化已在關鍵政策框架中得到正式規定。歐盟於2024年5月發布的《基本原料法案》設定了一個具有約束力的目標，即到2030年，歐盟將在其區域內加工其戰略原料（包括鋰）年消耗量的40%，旨在為高純度應用建立強大的區域原料基礎。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：醫藥級碳酸鋰的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依純度等級（99%、99%或更高）
    • 依用途（緩釋製劑、速釋製劑）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美藥用級碳酸鋰市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲藥用級碳酸鋰市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區醫藥級碳酸鋰市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲藥用級碳酸鋰市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲藥用級碳酸鋰市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球藥用級碳酸鋰市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Arcadium Lithium PLC
  • Albemarle Corporation
  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • American Elements Corp.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Panchsheel Organics Ltd
  • Blanver Farmoquimica e Farmaceutica SA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19577

The Global Pharmaceutical Grade Lithium Carbonate Market is projected to expand from USD 145.91 Million in 2025 to USD 184.73 Million by 2031, registering a CAGR of 4.01%. As a high-purity inorganic compound, this substance functions primarily as a vital mood stabilizer used to treat bipolar disorder and manic episodes. The market's foundation rests on the rising global incidence of mental health conditions and the broadening of psychiatric healthcare infrastructure, which guarantee steady demand for long-term pharmacological treatments. These fundamental drivers provide market stability that operates independently of industrial application cycles, protecting the sector from the volatility frequently observed in other chemical industries.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 145.91 Million
Market Size 2031USD 184.73 Million
CAGR 2026-20314.01%
Fastest Growing SegmentExtended Release
Largest MarketNorth America

However, the industry faces a substantial obstacle regarding raw material accessibility due to fierce competition from the electric vehicle market. This contest for lithium resources places stress on the supply chain and adds complexity to acquiring the feedstock necessary for medical purification. According to the U.S. Geological Survey, the medical sector represented roughly 1 percent of global lithium consumption in 2024, whereas the battery industry consumed 87 percent. This significant imbalance underscores how susceptible pharmaceutical production is to wider industrial supply deficits.

Market Driver

The increasing global incidence of bipolar and mood disorders serves as the main engine for the pharmaceutical grade lithium carbonate market, requiring continuous production of high-efficacy mood stabilizers. As mental health diagnoses become more accurate and destigmatization efforts grow, the population needing long-term pharmacological care has expanded substantially, establishing a stable demand base that contrasts with the cyclical patterns of battery usage. This trajectory is highlighted by the vast size of the affected demographic in key healthcare markets. According to Mental Health America's 'State of Mental Health in America 2025' report released in October 2025, 23.40 percent of adults in the United States experienced a mental illness in 2024, representing a massive group potentially requiring psychiatric intervention.

Concurrently, progress in high-purity lithium refining and extraction technologies is vital for enabling suppliers to satisfy medical requirements despite the dominance of the battery sector. Improved processing capabilities permit manufacturers to effectively isolate pharmaceutical-grade fractions from technical-grade brine, preventing supply limitations from hindering essential medication production. This operational expansion is evident in recent corporate metrics; according to Arcadium Lithium's 'Fourth Quarter and Full Year 2024 Results' from February 2025, total volumes sold in the fourth quarter rose by 56 percent on a Lithium Carbonate Equivalent basis compared to the third quarter, indicating enhanced output capacity. Such volume expansion is critical for stabilizing the medical supply chain amidst fluctuating market dynamics; according to the Shanghai Metal Market, the average spot price of battery-grade lithium carbonate settled at 75,050 yuan per metric ton by the end of 2024, suggesting a pricing landscape where efficient high-purity refining is a crucial competitive advantage for securing pharmaceutical feedstock.

Market Challenge

The intense competition for raw materials driven by the electric vehicle (EV) sector acts as a significant impediment to the expansion of the Global Pharmaceutical Grade Lithium Carbonate Market. As the automotive industry rapidly increases production to achieve decarbonization goals, it consumes the vast majority of available lithium feedstock, creating a critical bottleneck for other high-purity uses. This resource monopolization interferes with the supply chain for pharmaceutical producers, who depend on strictly regulated, high-grade lithium carbonate. The immense quantity of material redirected toward battery manufacturing restricts the availability of precursor compounds necessary for medical purification, compelling pharmaceutical firms to deal with supply instability and reduced negotiation leverage.

This disparity in resource allocation renders the medical sector extremely susceptible to the procurement tactics of major industrial entities. Since pharmaceutical demand involves comparatively lower volumes, manufacturers frequently struggle to obtain priority status from mining firms that prefer the massive, long-term offtake agreements characteristic of the battery sector. The scale of this inequality is highlighted by recent industrial figures. According to the International Lithium Association, global lithium demand hit roughly 1.3 million tonnes of lithium carbonate equivalent in 2024. This enormous consumption volume, spurred chiefly by energy storage requirements, effectively pushes the pharmaceutical market to the margins, making the reliable acquisition of essential raw materials an increasingly difficult and expensive undertaking.

Market Trends

The broadening of clinical research into neurodegenerative applications marks a pivotal evolution in the market, expanding lithium's utility beyond its conventional function in managing bipolar disorder. Studies are increasingly concentrating on lithium's neuroprotective capabilities for treating conditions like Alzheimer's disease, motivated by the pressing need to mitigate the growing economic and social impacts of dementia. This transition effectively enlarges the potential patient base for pharmaceutical-grade compounds, establishing a new long-term demand channel separate from psychiatric care. The significance of this opportunity is emphasized by the financial costs linked to these ailments; according to the Alzheimer's Association's '2024 Alzheimer's Disease Facts and Figures' report from March 2024, the total cost of care for individuals with Alzheimer's and other dementias in the United States was projected to hit $360 billion in 2024, underlining the substantial market incentive for developing effective lithium-based treatments.

At the same time, the rise of region-specific supply chains aimed at mitigating competition from the battery sector is transforming procurement strategies to safeguard medical inventory against industrial shortages. Governments are enacting legislation with domestic processing goals to guarantee that vital minerals remain accessible to critical sectors, including pharmaceuticals, rather than being wholly consumed by the Asian battery manufacturing network. This trend compels medical lithium purifiers to integrate with localized refining hubs that are shielded from global export instability. This structural shift is formalized in significant recent policy frameworks; according to the European Union's 'Critical Raw Materials Act' from May 2024, the legislation sets a binding target for the bloc to process 40 percent of its annual strategic raw material consumption, including lithium, domestically by 2030, thereby ensuring a robust regional feedstock foundation for high-purity applications.

Key Market Players

  • Arcadium Lithium PLC
  • Albemarle Corporation
  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • American Elements Corp.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Panchsheel Organics Ltd
  • Blanver Farmoquimica e Farmaceutica S.A.

Report Scope

In this report, the Global Pharmaceutical Grade Lithium Carbonate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Grade Lithium Carbonate Market, By Purity

  • 99%
  • Above 99%

Pharmaceutical Grade Lithium Carbonate Market, By Application

  • Extended Release
  • Immediate Release

Pharmaceutical Grade Lithium Carbonate Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Grade Lithium Carbonate Market.

Available Customizations:

Global Pharmaceutical Grade Lithium Carbonate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Purity (99%, Above 99%)
    • 5.2.2. By Application (Extended Release, Immediate Release)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Purity
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Purity
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Purity
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Purity
        • 6.3.3.2.2. By Application

7. Europe Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Purity
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Purity
        • 7.3.1.2.2. By Application
    • 7.3.2. France Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Purity
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Purity
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Purity
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Purity
        • 7.3.5.2.2. By Application

8. Asia Pacific Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Purity
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Purity
        • 8.3.1.2.2. By Application
    • 8.3.2. India Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Purity
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Purity
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Purity
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Purity
        • 8.3.5.2.2. By Application

9. Middle East & Africa Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Purity
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Purity
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Purity
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Purity
        • 9.3.3.2.2. By Application

10. South America Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Purity
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Purity
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Purity
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Purity
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Grade Lithium Carbonate Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Arcadium Lithium PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Albemarle Corporation
  • 15.3. Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • 15.4. American Elements Corp.
  • 15.5. Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • 15.6. Panchsheel Organics Ltd
  • 15.7. Blanver Farmoquimica e Farmaceutica S.A.

16. Strategic Recommendations

17. About Us & Disclaimer